facebook pixel Skip to main content

Low-Dose Lithium

The Mineral as Medicine

The first-ever, international online symposium on low-dose lithium!

Lithium remains underutilized and misunderstood in the field of medicine, but using this mighty mineral may in fact be one of the most promising treatments available. Discover novel protocols for integrating low-dose lithium as a safe, integrative treatment for psychiatric and neurological disorders. With these symposium lectures, you’ll learn from international experts – such as Professor Anjum Memon (lead author of the groundbreaking study on lithium and suicide), Julie Andersen, PhD, De-Maw Chuang, PhD, and James Greenblatt, MD – how to effectively integrate lithium into treatment for dementia, suicide prevention, traumatic brain injury (TBI), and more.

Watch the conference recordings now for only


Purchase the Conference Recording PackagePurchase the CME Version

CME Credit Available

Specific lectures from this conference have been approved for 7.5 AMA PRA Category 1 Credits™. This CME package is available for purchase separate from the full conference package. Learn more about certification for these conference lectures below.
Purchase the CME Lecture Package

Click to expand and read full accreditation information.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of MedicusCME and Comprehensive Psychiatric Resources, Inc.  MedicusCME is accredited by the ACCME to provide continuing medical education for physicians.

MedicusCME designates this live activity for a maximum of 7.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

June 20, 2022 through June 19, 2024

Lithium is a natural mineral with a history of use for mental health conditions. While effective for bipolar, it may also help with preventing suicide, reducing anger and aggression and preventing or treating other neurodegenerative conditions.


  • Review the background information, history and research on the use of lithium in medicine
  • Identify potential benefits of lithium including for preventing suicide and decreasing anger, irritability and aggression
  • Describe lithium’s biological mechanisms of action on brain function and its relationship to preventing Alzheimer’s disease
  • Elucidate the research suggesting therapeutic potential for lithium and Lyme disease, Parkinson’s disease, substance use disorder and cancer
  • Identify clinical indicators of lithium status and cautions for low-dose lithium supplementation

In order to receive AMA PRA Category 1 credit™, participants must do the following:

  • Read the learning objectives and faculty disclosures

  • Participate in the activity, review course content and learning strategies, resources and support materials provided

  • Complete the post-test and activity evaluation

  • Achieve a score of 80% or higher on the post-test

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of MedicusCME and Comprehensive Psychiatric Resources, Inc.  MedicusCME is accredited by the ACCME to provide continuing medical education for physicians.

MedicusCME designates this live activity for a maximum of 7.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

James Greenblatt, MD
Chief Medical Officer and Vice President of Medical Services
Walden Behavioral Care, Waltham, Massachusetts
Assistant Clinical Professor of Psychiatry
Tufts University School of Medicine
Boston, Massachusetts

MedicusCME requires instructors, planners, managers, and others in control of educational content to disclose all their financial relationships with ineligible companies over the previous 24 months. All identified financial relationships are thoroughly vetted and mitigated according to MedicusCME policy.

The faculty reported the following relevant financial relationships with Accreditation Council for Continuing Medical Education (ACCME)-defined ineligible entities related to the educational content of this CE activity.

James Greenblatt, MD has disclosed a financial relationship with Pure Encapsulations and Jaymac Pharmaceuticals for his role as consultant.

All other planners and faculty, including MedicusCME planners and managers, have no relevant financial relationships with ineligible companies to disclose. Any relevant financial relationships listed for planners or content contributors have been mitigated according to MedicusCME policies.
This activity is not supported by funds from an ACCME-defined ineligible company.

In accordance with the Health Insurance Portability and Accountability Act (HIPAA), this educational activity, especially when utilizing patient cases for learning demonstration, will not include individually identifiable health information.

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the Food and Drug Administration (FDA). The planners of this activity do not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Convenient Education for Busy Providers

Trusted Researchers

Learn the latest about low-dose lithium from experts in functional medicine and nutritional psychiatry.

Evidence-Based Education

Discover comprehensive, scientific presentations with protocols you can immediately implement in your practice.

Convenient & Accessible

Benefit from hybrid learning and access presentations from any device, anywhere.

Purchase the conference lecture package now!


Why Low-Dose Lithium?

Present in trace amounts in the foods we eat and the water we drink, lithium is a critical nutrient for many aspects of human physiology. While it has been widely prescribed and researched as a mood stabilizing drug, it continues to be one of the most slandered and misunderstood therapies in medicine. Erroneously, much of the public – as well as some health professionals – continues to think of lithium almost exclusively as a high-dose drug. As a naturally-occurring mineral, lithium can be utilized in micro-doses mimicking those found in our food and water supplies to balance brain chemistry safely and effectively.

Low-dose lithium has shown to be effective in a variety of applications, from treating Alzheimer’s, depression, and traumatic brain injury to preventing suicide. A novel, evidence-based model, focused on prevention and inclusion of low-dose lithium, may help us reduce suffering and bolster mental wellness in ways we’ve not thought possible before. To learn more, check out our articles or visit LowDoseLithium.com.

Symposium Presenters

Julie Andersen PhD

Julie Andersen, PhD

Click to Read Bio

Dr. Andersen received her PhD from the Department of Biological Chemistry in the David Geffen School of Medicine at the University of California, Los Angeles. She received additional research training in the Department of Neurogenetics at Massachusetts General Hospital in Boston. Prior to arriving at the Buck Institute, Dr. Andersen held a faculty position in the School of Gerontology at the University of Southern California. Dr. Andersen has published more than 170 scientific papers and holds three current patents. She has been recognized for her research with a Parkinson’s Pioneer Award from the National Parkinson’s Foundation, a Glenn Award for Research in Biological Mechanisms of Aging, and a senior scholarship from the Ellison Medical Foundation. She was elected a fellow of the Society for Free Radicals in Biology and Medicine in 2013. She currently serves on the scientific advisory board for the University of Pittsburgh Medical Center’s Biology of Aging Program, on the editorial board of e-Neuro (Journal of Neuroscience’s e-journal), as a member of the Brookdale Institute on Aging, and as a council member for the Society of Neurotoxicity. Dr. Andersen has extensive experience working with both biotech companies and medical foundations, including Roche, the Michael J. Fox Foundation, the National Parkinson’s Disease Foundation, and the American Parkinson’s Disease Foundation.

DeMaw Chuang PhD

De-Maw Chuang, PhD

Click to Read Bio

De-Maw Chuang, PhD joined the Intramural Research Program (IRP) of NIMH, NIH in 1973 and is the former Chief of the Molecular Neurobiology section. His research there centered on the mechanisms and actions of mood stabilizing drugs for bipolar disorder, notably lithium and valproate. His group was one of the first to demonstrate neuroprotective effects of these drugs and to explore their potential use for the treatment of a variety of neurodegenerative and neuropsychiatric disorders such as Alzheimer’s disease, stroke, traumatic brain injury and Huntington’s disease. Dr. Chuang retired from the IRP of NIMH, NIH and became a Scientist Emeritus of the IRP in January 2016. His research at the IRP resulted in about 270 publications and over 22,000 citations with an H-index of 85. For his innovative research, Dr. Chuang has received numerous honors and awards including the NIH Director’s Award in 1997, NARSAD (National Alliance for Research on Schizophrenia and Depression) Distinguished Investigator Award in 2002, Academician of Academia Sinica in Taiwan in 2006, Fellow of American College of Neuropsychopharmacology (ACNP ) in 2010, Best Mentor of the Year from the NIMH Director in 2010, Outstanding Mentor Award from the IRP of NIMH in 2011, and Outstanding Alumni Award of National Taiwan University in 2012.

John Endres ND

John Endres, ND

Click to Read Bio

Dr. Endres is the chief scientific officer for AIBMR Life Sciences, Inc. in Seattle, Washington since 2006. He earned a degree in naturopathic medicine at Bastyr University in Kenmore, Washington in 2004 and is licensed by Washington State Department of Health as a physician. He is a toxicologist and full member of the Society of Toxicology (SOT). Dr. Endres has been a member of numerous expert panels assembled for the evaluation of GRAS Independent Conclusions. He meets frequently with FDA Office of Food Additive Safety (OFAS) in College Park, MD for FDA GRAS pre-notification meetings. Dr. Endres has been a contributing author on many toxicological safety assessments that are published in academic journals specializing in toxicology. He is frequently the monitoring scientist for toxicology studies designed to study the safety of ingredients to be added to foods and dietary supplements. Dr. Endres is on the Editorial Advisory Boards for Nutritional Outlook, and is on the Executive Advisory Board for Vitafoods Europe. At AIBMR, he manages a team of scientific and regulatory consultants specializing in the natural products and functional foods industries.

Sudhir Gadh

Sudhir Gadh, MD

Click to Read Bio

Sudhir Gadh, MD, is a board-certified psychiatrist with a private practice in Union Square, New York City. He is also a Commander in the US Navy Reserve and the Medical Director for the Center for Recovery and Wellness. After completing his undergraduate degree at New York University in New York City, Dr. Gadh earned his medical degree at St. George’s University Medical School. He went on to his residency at the State University of New York at Stony Brook where he received the Steven Samek Award for Compassionate Care. Following residency, Dr. Gadh worked as an Attending at Bellevue Hospital Center and taught pharmacology at the NYU School of Medicine, both in New York City. Dr. Gadh is a member of the American Psychiatric Association and is also a psychiatrist at the New Life School for special needs children in the Bronx.

Dr. Gadh offers progressive psychiatric care that combines medication and therapy to help patients identify the core issues contributing to their mental health conditions. His comprehensive approach encourages patients to accept their value but demand and achieve improvement nonetheless. He supports healthy behavioral changes, including enhancing your diet, exercise, and sleeping habits to optimize brain health. He also prescribes medication to help patients improve or heal brain functioning, but he doesn’t believe patients must rely on medication as a long-term solution.  Dr. Gadh is the author of Low-dose lithium impact in an addiction treatment setting, published in July 2020, in Personalized Medicine in Psychiatry.

Orestis Giotakos MD PhD

Orestis Giotakos, MD, MSc, PhD

Click to Read Bio

Orestis Giotakos graduated from the Military Medical School, University of Thessaloniki, Greece, and he has been working as a Military Psychiatrist since 1992. He obtained his M.Sc. in Neuroscience at the Institute of Psychiatry, London, and his Ph.D. at the Medical School of Athens. He has conducted several investigations and has written a number of articles and books in psychopathology and in prevention strategies. He is the founder of the npo “obrela – Neuroscience & Mental Health,” the editor of the journal, Dialogues in Clinical Neuroscience & Mental Health, and the director of the project, I Care for My Brain.

James Greenblatt MD

James Greenblatt, MD

Click to Read Bio

A pioneer in the field of integrative medicine, James M. Greenblatt, MD, has treated patients since 1988. After receiving his medical degree and completing his psychiatry residency at George Washington University, Dr. Greenblatt completed a fellowship in child and adolescent psychiatry at Johns Hopkins Medical School. He served as the Chief Medical Officer at Walden Behavioral Care in Waltham, MA for nearly 20 years, and is an Assistant Clinical Professor of Psychiatry at Tufts University School of Medicine and Dartmouth College Geisel School of Medicine. Dr. Greenblatt has lectured internationally on the scientific evidence for nutritional interventions in psychiatry and mental illness. He is also the founder of Psychiatry Redefined, and author of eight books, including Finally Focused: The Breakthrough Natural Treatment Plan for ADHD, and Nutritional Lithium: A Cinderella Story.

Erick Jakobsson PhD

Eric Jakobsson, PhD

Click to Read Bio

Eric Jakobsson is a professor in the Departments of Molecular and Integrative Physiology and of Biochemistry and at the University of Illinois at Urbana-Champaign. He is a senior research scientist at the US National Center for Supercomputing Applications, and a professor in the Beckman Institute for Advanced Science and Technology at the University of Illinois at Urbana-Champaign. His research interests include computational biochemistry in the use of simulations to understand the physical, chemical bases of biomolecular function, bioinformatics in the use of advanced information, and technology to extract meaning from databases containing information on sequence, structure, and function. Dr. Jakobsson received his PhD in physics from Dartmouth College.

Anjum Menom

Prof. Anjum Memon, MBBS, DPhil [Oxon], FFPH

Click to Read Bio

Professor Anjum Memon is a medically qualified epidemiologist and public health academic, and currently serves as the Chair in Epidemiology and Public Health Medicine at Brighton and Sussex Medical School (BSMS). He trained in epidemiology at the University of Oxford under the supervision of Sir Richard Doll FRS – the eminent epidemiologist who discovered the main hazards of smoking. Anjum joined BSMS in 2005, having previously worked at the Universities of Oxford, Kuwait and Cambridge. He is a Fellow of the Faculty of Public Health and an Honorary Consultant in Public Health Medicine. Along with teaching, research and public health service work, Anjum contributes to capacity building, training and quality assurance activities in public health. Professor Memon is the lead author on the recent, groundbreaking study about the link between lithium in drinking water and lower rates of suicide. To learn more about Dr. Memon’s research, teaching and publications, click here.

James Phelps MD

James Phelps, MD

Click to Read Bio

Dr. James Phelps is a psychiatrist who has focused his practice on complex mood disorders for the last 20 years. In addition to full-time patient care, from which he is now mostly retired, he has been a “closet academic”, publishing articles on bipolar disorders and more recently on his clinic’s variation of the “Collaborative Care Model”, a system of psychiatric consultation in primary care. He currently serves as Research Editor for the Psychopharmacology Institute, preparing monthly “Quick Take” podcasts summarizing recent psychiatric articles; and is working on a video series on bipolar spectrum disorders.

Order the Conference Lecture Package Now

Symposium Lectures

Lithium in Drinking Water is Associated with Lower Suicide Rates – A Review of Epidemiological Evidence – Anjum Memon, MBBS, Dphil (Oxon), FFHP
A New Avenue for Lithium: Intervention in Traumatic Brain Injury – DeMaw Chuang, PhD
Low-Dose Lithium as a Treatment for Parkinson's and Other Neurodegenerative Diseases – Julie Andersen, PhD
Understanding the Effects of Lithium on Cancer – Eric Jakobsson, PhD
A Toxicological Evaluation of Lithium Orotate – John Endres, ND
Lithium for Alzheimer's Prevention – What Are We Waiting For? – James Phelps, MD
Amplifying Addiction Treatment with Low-Dose Lithium – Sudhir Gadh, MD
Impulsivity and Lithium Deficiency – Orestis Giotakos, MD, MSc, PhD
Irritability, Anger, and Rage - Syndromes of Lithium Deficiency – James Greenblatt, MD

Want an event preview?

Listen to the recent interview, Mapping Nutritional Lithium, with Dr. James Greenblatt.

Ready to learn more?

Explore more about low-dose lithium below.